Genotyping of Viral Glycoprotein B (gB) in Hematopoietic Stem Cell Transplant Recipients with Active Cytomegalovirus Infection: Analysis of the Impact of gB Genotypes on the Patients’ Outcome

Czech version

Authors: Roubalová K . ¹; O. Strunecký ²; S. Žufanová ²; B. Procházka ²; A. Vítek ³
Authors‘ workplace: Vidia s. r. o., Vestec ¹; Státní zdravotní ústav, Praha ²; Ústav hematologie a krevní transfuze, Praha ³
Published in: Epidemiol. Mikrobiol. Imunol. 59, 2010, č. 2, s. 92-99

Overview

Aim of the study:
Genetic variation of CMV strains may correlate with their pathogenicity for immunocompromised patients. On the basis of sequence variation in the UL55 gene encoding the most abundant viral envelope glycoprotein gB, CMV can be classified into four major gB genotypes. The aim of the study was the analysis of the distribution of gB genotypes in a cohort of haematopoietic stem cell transplant (HSCT) recipients and of the correlation of genetic polymorphisms with clinical outcomes and manifestation of CMV infection.

Material and methods:
Archived DNA isolates from consecutive blood samples of 53 adult allogeneic HSCT recipients with active CMV infection, transplanted in 2004-2005, were used for the genetic analysis. HCMV gB genotyping was performed by restriction fragment length polymorphism (RFLP) analysis and sequencing of the central variable region of UL55. The association of gB genotypes with selected clinical parameters was assessed by multivariate analysis after adjustment for graft donor type, HLA-matching and anti-thymocyte immunoglobulin (ATG) therapy.

Results:
gB1, gB2, gB3, and gB4 genotypes were detected in 30%, 17%, 26% and 4% of the patients, respectively. An atypical gB genotype was found in one patient. Co-infection with two or more gB genotypes was revealed in 17% of the patients. The distribution of gB genotypes did not vary in time, despite the fact that the patients transplanted in 2005 had more severe CMV infection with higher viral loads in the blood than those transplanted in 2004. gB1 was associated with a lower viral load (p = 0.046) and a milder course of symptomatic CMV infection, but with a higher rate of acute graft versus host disease (OR 3.4; p = 0.067). Pancytopenia was less frequent in the patients infected with gB3 (OR 0.09; p = 0.075). In contrast, gB2-infected patients had a worse outcome of CMV infection with a higher rate of organ involvement and were less responsive to antiviral therapy (OR 6.65 and 0.18; p = 0.15 and 0.12, respectively). The prognostic impact of co-infection with two or more gB genotypes was not shown.

Conclusions:
gB genotype may have an impact on the course of CMV infection and its complications in HSCT recipients. Nevertheless, these results need to be tested on a larger group of patients in the context of genetic variability of other functionally important viral genes. The characterization of viral genetic factors determining CMV pathogenesis will be of relevance to the treatment of patients at high risk of CMV infection.

Key words:
human cytomegalovirus, pathogenesis, hematopoietic stem cell transplantation, genotype, gB.

Sources

1. Hebart, H. Einsele, H. Clinical aspects of CMV infection after stem cell transplantation. Human immunology 2009,65, 432-436.

2. Razonable, R.R. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Amer j health-syst pharm 2005, 62, 57-79.

3. Lasry, S., Dény, P., Asselot, C., Rauzy, M., et. al. Interstrain variations in the cytomegalovirus (CMV) glycoprotein B gene sequence among CMV-infected children attending six day care centers. J Infect Dis 1996, 174, 606-609.

4. Rasmussen, L., Geissler, A., Winters, M. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J Infect Dis 2003 187, 809-819.

5. Pignatelli, S., Dal Monte, P., Rossini, G., Landini, M.P. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004, 14, 383-410.

6. Britt, W.J., Vugler, L.G. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J Virol 1989, 63, 403-410.

7. Boehme, K. W., Singh, J., Perry, S. T., Compton, T. Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J Virol 2004,78, 1202-1211.

8. Alberola, J, Tamarit, A, Igual, R, Navarro, D. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection. J Clin Virol 2000,16 , 113-122.

9. Chou, S.W., Dennison, K.M. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991,163, 1229-1234.

10. Boeckh, M. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy. Transpl Infect Dis 1999,1, 165-178.

11. Pumannová, M., Roubalova, K., Vítek, A., Sajdová, J. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation. Diag Microbiol Infect Dis 2006, 54, 115-120.

12. Aquino, V.H., Figueiredo, L.T. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 2000, 61, 138-142.

13. Terabe, K., Sugiyama, K., Goto, K., Mizutani, F., et. al. Relationship between human cytomegalovirus glycoprotein B genotype and serum alanine aminotransferase elevation in infants. Tohoku J Exp Med 2004, 203, 339-344.

14. Jin, H., Wang, X., Li, S. Human cytomegalovirus glycoprotein B genotype correlates with different symptoms of infected infants. Intervirology 2007,50, 219-223.

15. Yu, Z. S., Zheng, J. Y., Wu , J. B. Association between clinical manifestations of infants with human cytomegalovirus infection and glycoprotein B genotype. Zhonghua Yi Xue Za Zhi 2007,87, 259-261.

16. Yan, H., Koyano, S., Inami, Y., et. al. Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 2008,153, 667-674.

17. Bale, J.F. Jr, Murph, J.R., Demmler, G.J., Dawson, J., et. al. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 2000, 182, 933-936.

18. Zipeto, D., Hong, C., Gerna, G., Zavattoni, M., et. al. Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. AIDS Res Hum Retroviruses 1998, 14, 533-536.

19. Fidouh-Houhou, N., Duval, X., Bissuel, F., Bourbonneux, V., et. al. Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis 2001, 33, 1406-1411.

20. Shepp, D.H., Match, M.E., Ashraf, A.B., Lipson, S.M., et. al. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996, 174, 184-187. .

21. Chern, K.C., Chandler, D.B., Martin, D.F., Kuppermann, B.D., et. al. Glycoprotein B subtyping of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J Infect Dis 1998,178, 1149-1153.

22. Tarragů, D., Quereda, C., and Tenorio, A. Different cytomegalovirus glycoprotein B genotype distribution in serum and cerebrospinal fluid specimens determined by a novel multiplex nested PCR. J Clin Microbiol 2003, 41, 2872-2877.

23. Gilbert, C, Handfield, J, Toma, E, Lalonde, R, et. al. Human cytomegalovirus glycoprotein B genotypes in blood of AIDS patients: lack of association with either the viral DNA load in leukocytes or presence of retinitis. J Med Virol 1999, 59, 98-103.

24. Peek, R., Verbraak, F., Bruinenberg, M., Van der Lelij, A., et. al. Cytomegalovirus glycoprotein B genotyping in ocular fluids and blood of AIDS patients with cytomegalovirus retinitis. Invest Ophthalmol Vis Sci.1998 Jun;39(7):1183-7. 39, 1183-1187.

25. Drew, W. L., Chou, S., Miner, R. C., Mohr, B. A., et. al. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 2002, 186, 114-117.

26. Humar, A., Kumar, D., Gilbert, C., Boivin, G. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 2003, 188, 581-584.

27. Pacsa, A. S., Essa, S., Voevodin, A., el-Shazly, A., et. al. Correlation between CMV genotypes, multiple infections with herpesviruses (HHV-6,7) and development of CMV disease in kidney recipients in Kuwait. FEMS Immunol Med Microbiol 2003, 35, 125-130.

28. Binder, T., Siegert, W., Kruse, A., Oettle, H., et. al. Identification of human cytomegalovirus variants by analysis of single strand conformation polymorphism and DNA sequencing of the envelope glycoprotein B gene region-distribution frequency in liver transplant recipients. J Virol Methods 1999, 78, 153-162.

29. Vogelberg, C., Meyer-König, U., Hufert, F.T., Kirste, G., von Laer, D. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 1996, 50, 31-34.

30. Coaquette, A., Bourgeois, A., Dirand, C., Varin, A., et. al. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 2004, 39, 155-161.

31. Puchhammer-Stückl, E., GŲrzer, I., Zoufaly, A., Jaksch, P., et. al. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 2006, 81, 187-194.

32. Sarcinella, L., Mazzulli, T., Willey, B., Humar, A. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol 2002, 24, 99-105.

33. Fries, B.C., Chou, S., Boeckh, M., Torok-Storb, B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994169, 769-774.

34. Torok-Storb, B., Boeckh, M., Hoy, C., Leisenring, W., et. al. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 1997, 90, 2097-2102.

35. Meyer-König, U., Vogelberg, C., Bongarts, A., Kampa, D., et. al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998, 55, 75-81.

36. Rosen, H.R., Corless, C.L., Rabkin, J., Chou, S. Association of cytomegalovirus genotype with graft rejection after liver transplantation. Transplantation 1998, 66, 1627-1631.

37. Hebart, H, Greif, M, Krause, H, Kanz, L, et. al. Interstrain variation of immediate early DNA sequences and glycoprotein B genotypes in cytomegalovirus clinical isolates. Med Microbiol Immunol 1997, 186, 135-138.

38. Woo, P.C., Lo, C.Y., Lo, S.K., Siau, H., et. al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 1997, 4, 515-518.

39. Retiťre, C., Lesimple, B., Lepelletier, D., Bignon, J. D., et. al. Association of glycoprotein B and immediate early-1 genotypes with human leukocyte antigen alleles in renal transplant recipients with cytomegalovirus infection. Transplantation 2003, 75, 161-165.

40. Roubalová, K., Žufanová, S., Vítek, A., Staňková, M. zastoupení různých genotypů glykoproteidu gB u pacientů s vysokým rizikem symptomatické infekce lidským cytomegalovirem (CMV). Epidemiol Mikrobiol Imunol 2009, 58, 148-153.

Labels

Hygiene and epidemiology Medical virology Clinical microbiology

Mobile Genetic Elements in the Epidemiology of Bacterial Resistance to Antibiotics

Opportunistic Pathogen Candida glabrata and the Mechanisms of its Resistance to Antifungal Drugs

Susceptibility of Staphylococcus aureus Biofilms to Vancomycin, Gentamicin and Rifampin

Antibiotic Resistance and Biofilm Formation in Staphylococcus saprophyticus Strains Isolated from Urine

Article was published in

Epidemiology, Microbiology, Immunology

2010 Issue 2